MarketPeel
Insider Trading Intelligence
AM

Amy E. Mckee

BCRX
DIRECTOR · BIOCRYST PHARMACEUTICALS INC · CIK 0001883764
FILING MIX · LIFETIME88%/12%
BUYS
15
SELLS
2
TOTAL VALUE
$177.1K
COMPANIES
1
ACTIVE SINCE
Sep 2021
HOLDINGS NOW
33,540
AVG SELL PX
$7.82
TRADE KIND
SHOWING 17 / 17
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Amy E. Mckee, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+6.38%+0.48%+5.90%+5.90%
14d1+0.00%+2.39%+2.31%+0.08%+0.08%
30d1+0.00%+18.02%-0.28%+18.30%+18.30%
60d1+0.00%+29.19%+3.57%+25.61%+25.61%
90d1+0.00%+24.24%+5.28%+18.96%+18.96%
180d1+0.00%+20.73%+9.62%+11.11%+11.11%
1y1+0.00%+58.37%+12.86%+45.52%+45.52%
2y1+0.00%+47.93%+35.16%+12.76%+12.76%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BCRX · 33,540 shares · as of Jun 11, 2026
013,33326,66740,00053,33320222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 15 buys / 2 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,29447,177Jun 11, 2026Jun 15, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
33,54033,540Jun 11, 2026Jun 15, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
631$8.91$5.6K31,883May 29, 2026Jun 2, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
11,180$8.97$100.3K31,252May 18, 2026May 19, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
642$8.75$5.6K42,432Feb 27, 2026Mar 3, 2026View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
783$7.18$5.6K41,790Nov 28, 2025Dec 2, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
676$8.31$5.6K41,007Aug 29, 2025Sep 3, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
27,18127,181Jun 12, 2025Jun 16, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,50040,331Jun 12, 2025Jun 16, 2025View →
BCRX
BIOCRYST PHARMACEUTICALS INC
SALE
8,600$6.32$54.4K27,831Jun 24, 2024Jun 25, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
49,93349,933Jun 12, 2024Jun 14, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,82036,431Jun 12, 2024Jun 14, 2024View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
39,07239,072Jun 13, 2023Jun 15, 2023View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
16,74529,611Jun 13, 2023Jun 15, 2023View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
30,02230,022Jun 7, 2022Jun 9, 2022View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
12,86612,866Jun 7, 2022Jun 9, 2022View →
BCRX
BIOCRYST PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
53,33353,333Sep 20, 2021Sep 22, 2021View →
Other insiders · BCRX
Loading peer insiders…
About this filer
CIK 0001883764
ROLE
Director
PRIMARY
BCRX
COMPANIES
1
ACTIVE SINCE
Sep 2021
MARKETPEEL · /INSIDER/0001883764DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback